James Robert Noble, MD | |
255 Bert Kouns Loop, Shreveport, LA 71106-8150 | |
(318) 683-0411 | |
(318) 603-5461 |
Full Name | James Robert Noble |
---|---|
Gender | Male |
Speciality | Urology |
Experience | 39 Years |
Location | 255 Bert Kouns Loop, Shreveport, Louisiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1902801467 | NPI | - | NPPES |
340012716 | Other | LA | RAILROAD MEDICARE |
1371017 | Medicaid | LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | 07300 (Louisiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ochsner Lsu Health Shreveport-st Mary Medical Cent | Shreveport, LA | Hospital |
Christus Health Shreveport - Bossier | Shreveport, LA | Hospital |
Ochsner Lsu Health Shreveport | Shreveport, LA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Lsu Health Sciences Center Shreveport Faculty Group Practice | 4082902721 | 529 |
News Archive
Shared Health, Inc., Tennessee's largest public/private health information exchange (HIE) has partnered with MEDai, an Elsevier company, to provide a rich, interoperable, clinically relevant HIE platform to the state of Tennessee. This partnership delivers best in class solutions and technologies that support clinical excellence and operating efficiencies.
By combining conventional spectroscopy with sophisticated mapping and imaging technology in its SyNIRgi chemical imaging system and ISys chemical imaging software, Malvern Panalytical has greatly extended the application of vibrational spectroscopy.
Kitov Pharmaceuticals, an innovative biopharmaceutical company focused on late-stage drug development, announced today that the Phase III, double-blind, placebo-controlled clinical trial for its leading drug candidate, KIT-302, successfully met the primary efficacy endpoint of the trial protocol as approved by the U.S. Food & Drug Administration (FDA).
Tumor cells collected during the removal of a cancerous bladder and - in some cases - transplanted into mice with weakened immune systems, could help physicians rapidly identify high-risk cancers, determine prognosis and refine the use of biomarkers to personalize care for patients with this common cancer, according to a study published online on Oct. 24, 2016, in Scientific Reports.
Sundia MediTech Company, a leading pharmaceutical R&D outsourcing service company in China, is proud to announce that the company received the Red Herring Asia Top 100 Enterprises 2009 award, an award given to the top 100 private technology companies in the Asia Pacific region.
› Verified 9 days ago
Entity Name | Lsu Health Sciences Center Shreveport Faculty Group Practice |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013374222 PECOS PAC ID: 4082902721 Enrollment ID: O20161012000307 |
News Archive
Shared Health, Inc., Tennessee's largest public/private health information exchange (HIE) has partnered with MEDai, an Elsevier company, to provide a rich, interoperable, clinically relevant HIE platform to the state of Tennessee. This partnership delivers best in class solutions and technologies that support clinical excellence and operating efficiencies.
By combining conventional spectroscopy with sophisticated mapping and imaging technology in its SyNIRgi chemical imaging system and ISys chemical imaging software, Malvern Panalytical has greatly extended the application of vibrational spectroscopy.
Kitov Pharmaceuticals, an innovative biopharmaceutical company focused on late-stage drug development, announced today that the Phase III, double-blind, placebo-controlled clinical trial for its leading drug candidate, KIT-302, successfully met the primary efficacy endpoint of the trial protocol as approved by the U.S. Food & Drug Administration (FDA).
Tumor cells collected during the removal of a cancerous bladder and - in some cases - transplanted into mice with weakened immune systems, could help physicians rapidly identify high-risk cancers, determine prognosis and refine the use of biomarkers to personalize care for patients with this common cancer, according to a study published online on Oct. 24, 2016, in Scientific Reports.
Sundia MediTech Company, a leading pharmaceutical R&D outsourcing service company in China, is proud to announce that the company received the Red Herring Asia Top 100 Enterprises 2009 award, an award given to the top 100 private technology companies in the Asia Pacific region.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
James Robert Noble, MD 255 Bert Kouns Loop, Shreveport, LA 71106-8150 Ph: (318) 683-0411 | James Robert Noble, MD 255 Bert Kouns Loop, Shreveport, LA 71106-8150 Ph: (318) 683-0411 |
News Archive
Shared Health, Inc., Tennessee's largest public/private health information exchange (HIE) has partnered with MEDai, an Elsevier company, to provide a rich, interoperable, clinically relevant HIE platform to the state of Tennessee. This partnership delivers best in class solutions and technologies that support clinical excellence and operating efficiencies.
By combining conventional spectroscopy with sophisticated mapping and imaging technology in its SyNIRgi chemical imaging system and ISys chemical imaging software, Malvern Panalytical has greatly extended the application of vibrational spectroscopy.
Kitov Pharmaceuticals, an innovative biopharmaceutical company focused on late-stage drug development, announced today that the Phase III, double-blind, placebo-controlled clinical trial for its leading drug candidate, KIT-302, successfully met the primary efficacy endpoint of the trial protocol as approved by the U.S. Food & Drug Administration (FDA).
Tumor cells collected during the removal of a cancerous bladder and - in some cases - transplanted into mice with weakened immune systems, could help physicians rapidly identify high-risk cancers, determine prognosis and refine the use of biomarkers to personalize care for patients with this common cancer, according to a study published online on Oct. 24, 2016, in Scientific Reports.
Sundia MediTech Company, a leading pharmaceutical R&D outsourcing service company in China, is proud to announce that the company received the Red Herring Asia Top 100 Enterprises 2009 award, an award given to the top 100 private technology companies in the Asia Pacific region.
› Verified 9 days ago
Ralph Jonathan Henderson, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 255 Bert Kouns, Shreveport, LA 71106 Phone: 318-683-0411 Fax: 318-603-5461 | |
Dennis Dale Venable, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1501 Kings Hwy, Department Of Urology, Shreveport, LA 71103 Phone: 318-813-2750 Fax: 318-813-2755 | |
Alison Smith Spann, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 255 Bert Kouns Industrial Loop, Shreveport, LA 71106 Phone: 318-683-0411 Fax: 318-688-8525 | |
Dr. Kara N Babaian, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1501 Kings Hwy, Shreveport, LA 71103 Phone: 318-675-5601 | |
Raymond Wendell Turner, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 9854 Jennifer Ln, Shreveport, LA 71106 Phone: 318-797-5786 | |
Dr. Tajammul N Fazili, MD Urology Medicare: Medicare Enrolled Practice Location: 510 E Stoner Ave, Shreveport, LA 71101 Phone: 318-221-8411 | |
Mrs. Ashley Sittig Baker, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 255 Bert Kouns, Shreveport, LA 71106 Phone: 318-683-0411 Fax: 318-603-5461 |